Study Addresses Dilemmas Regarding Newborn Screening and SMA Treatment

Study Addresses Dilemmas Regarding Newborn Screening and SMA Treatment

As newborn screening for spinal muscular atrophy (SMA) becomes more common, ethical dilemmas will arise about the best treatment strategy for individuals with four copies of the SMN2 gene, a new study contends. The study, “Infants Diagnosed with Spinal Muscular...